Patent holdings for IPC class A61K 39/00

Total number of patents in this class: 50204

10-year publication summary

2830
3301
3714
3645
3498
3675
3188
2664
4694
3823
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Immatics Biotechnologies GmbH
1155
890
Regeneron Pharmaceuticals, Inc.
4377
587
The Regents of the University of California
20195
586
The Trustees of the University of Pennsylvania
4374
511
Glaxosmithkline Biologicals S.A.
1653
492
Genentech, Inc.
4014
483
The United States of America, as represented by the Secretary, Department of Health and Human Services
2892
474
Novartis AG
10685
444
Amgen Inc.
4141
326
Janssen Biotech, Inc.
1573
321
The Board of Trustees of the Leland Stanford Junior University
6507
316
Memorial Sloan-Kettering Cancer Center
1968
311
Hoffmann-La Roche Inc.
3504
294
Board of Regents, The University of Texas System
5906
283
Bristol-myers Squibb Company
4847
270
Inserm (institut National de La Sante et de La Recherche Medicale)
3369
266
Pfizer Inc.
3379
256
Dana-Farber Cancer Institute, Inc.
2607
253
The General Hospital Corporation
4789
210
The Johns Hopkins University
5731
207
Other owners 42424